Financials
Financial year 2025
BELGOPHARMA from Anderlecht, company number BE0762935682, closed financial year 2025 with a result of € 412,067 after tax. For that financial year BELGOPHARMA recorded a gross margin of € 754,756 and equity of € 2.7 million. Compared with financial year 2024, the result moved from € 1.2 million to € 412,067. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
€ 2.7 million
▲ 18% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 412,067
▼ 67% vs 2024
Profit after tax over the fiscal year.
€ 1.3 million
▼ 31% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2.7 million.
People and assets in 2025
€ 12,344
▲ 227% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 548,770
▲ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 401,998
▼ 25% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 3,845,525 | - | - | - | |
| Gross margin | € 583,644 | € 885,204 | € 1,768,278 | € 754,756 | ▼ 57% |
| Profit after taxes | € 412,578 | € 586,699 | € 1,235,354 | € 412,067 | ▼ 67% |
| Equity | € 440,520 | € 1,027,219 | € 2,262,574 | € 2,674,640 | ▲ 18% |
| Total debts | € 1,263,341 | € 925,771 | € 1,053,696 | € 957,585 | ▼ 9% |
| Cash | € 441,880 | € 762,599 | € 1,920,722 | € 1,328,708 | ▼ 31% |
| Retained profit | € 434,320 | € 1,021,019 | € 2,256,374 | € 2,668,440 | ▲ 18% |
| Balance sheet total | € 1,703,861 | € 1,952,990 | € 3,316,269 | € 3,632,225 | ▲ 10% |
By gross margin, BELGOPHARMA ranks 7th of 13 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Anderlecht that publish figures (fiscal year 2025).
Key figures of BELGOPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about BELGOPHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to BELGOPHARMA?
What happened at BELGOPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 412,067 (▼ 67% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Anderlecht. KBO
In short
From € 412,578 profit in 2022 to € 412,067 profit in 2025.
Paid € 1.2 million in corporate taxes since 2022.
Best year ever: 2024, with € 1.2 million profit.
Establishments
Establishment units
Physical locations of this company
Bergense Steenweg 1160
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Anderlecht
Same main activity (Groothandel in farmaceutische en medische artikelen), 32 active companies in Anderlecht, largest first.
€ 4.6 billion revenue · 2025
CENTRE EUROPEEN DE REPARTITION PHARMACEUTIQUE
€ 580.7 million revenue · 2025
€ 472.7 million revenue · 2025
€ 448.8 million revenue · 2025
€ 152.2 million revenue · 2025
€ 131.2 million revenue · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- AMETTOUCH Anwar(oprichter) 50%
- MAMAGHANI Nioucha(oprichter) 50%
Details
- Company number
- 0762.935.682
- VAT number
- BE 0762.935.682
- Registered office
- Bergense Steenweg 1160, 1070 Anderlecht
- Names & denominations
- BELGOPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 February 2021
- Peppol
- Active · Active since 4 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen